WallStSmart
PETS

PetMed Express Inc

NASDAQ: PETS · HEALTHCARE · PHARMACEUTICAL RETAILERS

$2.26
+2.25% today

Updated 2026-06-04

Market cap
$36.54M
P/E ratio
P/S ratio
0.19x
EPS (TTM)
$-2.74
Dividend yield
52W range
$2 – $4
Volume
0.1M

PetMed Express Inc (PETS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242026
Revenue$137.58M$162.25M$188.34M$219.41M$238.27M$231.64M$238.25M$227.83M$233.39M$229.40M$234.68M$249.18M$273.80M$283.42M$284.13M$303.58M$273.42M$256.58M$274.10M$226.97M
Revenue growth (YoY)+17.9%+16.1%+16.5%+8.6%-2.8%+2.9%-4.4%+2.4%-1.7%+2.3%+6.2%+9.9%+3.5%+0.2%+6.8%-9.9%-6.2%+6.8%-17.2%
Cost of revenue$83.24M$97.68M$114.12M$134.08M$146.41M$147.69M$158.09M$150.71M$155.77M$153.13M$158.39M$169.86M$175.99M$188.10M$202.88M$219.27M$198.08M$185.84M$196.38M$157.84M
Gross profit$54.34M$64.57M$74.21M$85.33M$91.86M$83.96M$80.17M$77.12M$77.62M$76.27M$76.30M$79.31M$97.81M$95.31M$81.25M$84.32M$75.34M$71.01M$77.71M$69.14M
Gross margin39.5%39.8%39.4%38.9%38.6%36.2%33.6%33.9%33.3%33.2%32.5%31.8%35.7%33.6%28.6%27.8%27.6%27.7%28.4%30.5%
R&D$0.00$0.00$0.00$0.00$0.00$0.00$0.00
SG&A$14.08M$17.29M$20.37M$21.60M$22.34M$22.20M$22.36M$21.59M$21.35M$21.10M$21.30M$22.80M$24.29M$24.77M$25.26M$28.29M$30.83M$49.47M$55.25M$38.65M
Operating income$18.15M$21.50M$28.00M$34.20M$40.54M$33.02M$26.02M$27.00M$28.22M$27.61M$32.39M$37.48M$52.14M$46.17M$30.98M$30.53M$25.71M$6.55M$-6.96M$-1.53M
Operating margin13.2%13.3%14.9%15.6%17.0%14.3%10.9%11.9%12.1%12.0%13.8%15.0%19.0%16.3%10.9%10.1%9.4%2.6%-2.5%-0.7%
EBITDA$18.69M$22.03M$28.59M$35.02M$41.86M$34.40M$27.43M$28.10M$29.09M$30.04M$33.16M$38.85M$54.26M$51.35M$36.15M$32.96M$29.81M$10.99M$783000.00$6.71M
EBITDA margin13.6%13.6%15.2%16.0%17.6%14.9%11.5%12.3%12.5%13.1%14.1%15.6%19.8%18.1%12.7%10.9%10.9%4.3%0.3%3.0%
EBIT$18.15M$21.50M$28.00M$34.20M$40.54M$33.02M$26.02M$27.00M$28.22M$29.38M$32.39M$37.48M$52.14M$49.12M$33.89M$30.53M$27.07M$7.45M$-6.27M$-330000.00
Interest expense$889950.00$1.70M$2.42M$1.46M$200000.00$253000.00$349000.00$301000.00$181000.00$185000.00$179000.00$441000.00$1.65M$2.95M$2.92M$1.21M$335000.00$3.01M$3.01M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$12.06M$14.44M$20.02M$22.98M$26.00M$20.87M$16.66M$17.16M$17.97M$17.45M$20.57M$23.82M$37.28M$37.74M$25.85M$23.92M$21.10M$5.14M$-7.46M$-6.27M
Net income growth (YoY)+19.7%+38.6%+14.8%+13.2%-19.7%-20.2%+3.0%+4.7%-2.9%+17.8%+15.8%+56.5%+1.2%-31.5%-7.5%-11.8%-75.6%-245.2%+16.0%
Profit margin8.8%8.9%10.6%10.5%10.9%9.0%7.0%7.5%7.7%7.6%8.8%9.6%13.6%13.3%9.1%7.9%7.7%2.0%-2.7%-2.8%

Frequently asked questions

What is PetMed Express Inc's revenue?

PetMed Express Inc's trailing twelve-month revenue is $179.02M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is PETS?

In its most recent fiscal year, PETS ran a gross margin of 30.46%, an operating margin of -0.67%, and a net margin of -2.76%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PETS generate?

PETS produced $-395000.00 in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.